Cardiovascular disease remains the leading cause of premature morbidity and mortality among patients with progressive renal impairment. Specifically, vascular calcification in CKD represents an aggressive and life-threatening complication that dramatically elevates cardiovascular risk. As renal function declines, mineral metabolism disturbances trigger the osteogenic transdifferentiation of vascular smooth muscle cells. These transformed cells adopt bone-forming capabilities, leading to hydroxyapatite deposition within the medial arterial layer. Consequently, patients experience progressive arterial stiffening, left ventricular hypertrophy, and reduced coronary perfusion.

Although traditional management strategies focus on phosphate control and mineral balance, clinical outcomes often remain suboptimal. Therefore, researchers actively seek deeper insights into the underlying cellular and molecular mechanisms of vascular remodeling. Recent discoveries highlight programmed cell death as a primary regulator of vascular homeostasis. In particular, anoikis—a specialized form of adhesion-dependent apoptosis—plays a crucial role in maintaining arterial architecture. When vascular cells lose contact with the extracellular matrix, anoikis pathways determine their survival or demise. However, the precise role of anoikis-related molecular signatures during arterial mineralization in renal disease has remained largely unexplored until now. This breakthrough study bridges that gap by applying multi-omics techniques to decipher these critical pathogenic cascades.

Mechanisms of Anoikis and Vascular Calcification in CKD

Anoikis functions as a physiological barrier that eliminates misplaced or detached cells, thereby preserving normal tissue architecture. Under healthy conditions, vascular smooth muscle cells maintain direct contact with surrounding extracellular matrix proteins through specialized integrin receptors. When pathological stressors disrupt this mechanical anchorage, cells normally trigger apoptotic signaling cascades. However, uremic toxins, oxidative stress, and hyperphosphatemia alter this protective response in chronic kidney disease. Consequently, vascular smooth muscle cells develop anoikis resistance, which enables aberrant cellular survival despite matrix detachment.

Furthermore, this acquired resistance allows phenotypic switching toward an osteochondrogenic lineage. Instead of undergoing clearance, these altered cells actively release matrix vesicles laden with calcium and phosphate. In addition, they downregulate endogenous calcification inhibitors while upregulating bone morphogenetic pathways. Dysregulated cell adhesion molecules further destabilize the vascular wall, accelerating extracellular matrix degradation and elastolysis. As a result, the vessel wall undergoes extensive architectural remodeling that promotes calcium crystal nucleation. Understanding the balance between anoikis sensitivity and osteogenic transdifferentiation thus reveals critical therapeutic vulnerabilities in progressive vascular calcification in CKD.

Integrative Transcriptomics and Cross-Species Gene Discovery

To map the genomic landscape of vascular mineralization, researchers conducted an integrative transcriptomic study combining human and animal experimental models. Specifically, they utilized an in vitro human vascular smooth muscle cell calcification model alongside an established rat model of chronic kidney disease-induced vascular calcification. The investigative team applied a unified statistical threshold with a false discovery rate below 0.05 and strict fold-change criteria to identify differentially expressed genes. Moreover, they implemented strict one-to-one ortholog mapping to ensure accurate cross-species comparability between rodent and human datasets.

Through this rigorous bioinformatics pipeline, the investigators screened forty-eight differentially expressed anoikis-related genes. Interestingly, the primary transcriptomic signals derived predominantly from human vascular smooth muscle cells rather than demonstrating complete evolutionary conservation in rodents. Functional enrichment analyses subsequently revealed that the cell adhesion molecule pathway was significantly dysregulated during active calcification. In addition, biological pathways governing matrix organization, focal adhesion signaling, and cell survival exhibited pronounced alterations. These findings demonstrate that human vascular smooth muscle cells utilize unique anoikis-dependent pathways during osteogenic switching, underscoring the critical necessity of validating rodent observations in human cardiovascular tissue models.

Machine Learning Validates a Seven-Gene Diagnostic Model

To distill clinically actionable biomarkers from complex transcriptomic data, the researchers employed three distinct machine-learning algorithms. Through this robust computational screening, they successfully identified seven core hub genes: BDNF, CRYAB, CYP1B1, DAPK1, HAS2, PDGFRB, and PLAU. Each of these genes regulates essential cellular processes, including extracellular matrix remodeling, chaperone-mediated cytoprotection, cell survival, and vascular smooth muscle cell homeostasis. For example, CRYAB provides molecular chaperone defense against cellular stress, whereas PDGFRB controls vascular smooth muscle proliferation and phenotype maintenance.

Similarly, DAPK1 and PLAU govern apoptotic cascades and pericellular proteolysis, directly influencing cell detachment and matrix degradation. When investigators combined these seven hub genes into a composite diagnostic model, the signature demonstrated exceptional discriminatory performance. Specifically, the model achieved an area under the receiver operating characteristic curve (AUC) of 0.811 within an independent external validation cohort. Furthermore, this high diagnostic accuracy confirms that anoikis-related transcriptional reprogramming closely mirrors the extent of vascular calcification. Consequently, this multigene panel holds substantial promise for future clinical risk stratification, enabling earlier identification of kidney disease patients vulnerable to severe medial arterial calcification.

Single-Cell Landscape Reveals Cell-Specific Anoikis Activity

Bulk transcriptomics provides broad pathway insights, but single-cell RNA sequencing reveals the precise cellular microenvironment governing arterial disease. In this study, single-cell analysis delineated distinct cell-type-specific expression profiles across the calcifying vascular wall. Most notably, the highest anoikis module scores localized within two specific subpopulations: osteoblast-like vascular cells and infiltrating macrophages. Osteoblast-like smooth muscle cells displayed profound dysregulation of matrix attachment proteins, which directly correlated with their pro-calcific secretory activity.

Meanwhile, vascular macrophages demonstrated heightened anoikis module activation alongside intense inflammatory signaling. These infiltrating immune cells actively produce matrix metalloproteinases and inflammatory cytokines, such as tumor necrosis factor-alpha and interleukin-1 beta. Consequently, macrophage-driven inflammation exacerbates local tissue destruction and accelerates smooth muscle cell detachment. This detrimental microenvironmental crosstalk creates a vicious cycle of ECM degradation, anoikis evasion, and osteogenic differentiation. Moreover, the single-cell resolution highlights how distinct vascular cell types collaborate to drive calcification pathology. Targeting these cell-specific interactions therefore represents a promising avenue for halting arterial mineralization in chronic kidney disease.

Translational Horizons for Nephrology and Cardiovascular Care

The discovery of anoikis-related molecular signatures provides vital translational insights for nephrologists and cardiologists managing chronic renal disease. Currently, clinicians lack reliable circulating biomarkers to detect subclinical medial calcification prior to irreversible arterial stiffening. Therefore, the seven hub genes identified in this investigation offer promising candidates for non-invasive molecular diagnostic assays. In addition, these findings illuminate novel therapeutic targets capable of preventing smooth muscle transdifferentiation. Pharmacological agents that restore physiological cell-matrix interactions or modulate chaperone-mediated cytoprotection could potentially halt calcification progression.

Furthermore, future research must validate these exploratory findings in large, diverse, clinical cohorts of patients with chronic kidney disease. Investigating how therapeutic interventions—such as non-calcium phosphate binders, calcimimetics, and sodium thiosulfate—influence anoikis signatures will also prove invaluable. Ultimately, bridging single-cell genomics with clinical nephrology will accelerate precision medicine approaches for high-risk patients. By targeting anoikis pathways and vascular cell homeostasis, clinicians may eventually reduce the devastating burden of cardiovascular mortality in renal disease.

Frequently Asked Questions

What is anoikis, and how does it drive vascular calcification in CKD?

Anoikis represents a specialized form of detachment-induced apoptosis that maintains tissue architecture. When vascular smooth muscle cells detach from their normal extracellular matrix, they typically undergo anoikis. However, under uremic conditions, phenotypic switching allows these cells to resist anoikis and undergo osteogenic transdifferentiation. Consequently, they release matrix vesicles and deposit calcium crystals within the arterial media, driving vascular stiffening, luminal narrowing, and cardiovascular disease progression in chronic kidney disease.

Which hub genes serve as key diagnostic biomarkers for vascular calcification?

The multi-omics analysis identified seven critical hub genes: BDNF, CRYAB, CYP1B1, DAPK1, HAS2, PDGFRB, and PLAU. Together, these genes govern extracellular matrix remodeling, cell adhesion pathways, chaperone-mediated cytoprotection, and smooth muscle cell homeostasis. In independent validation datasets, this seven-gene panel demonstrated strong diagnostic capability with an area under the curve of 0.811. Therefore, these molecular signatures offer promising translational value for early risk stratification and targeted therapeutic intervention in high-risk patients.

How do osteoblast-like cells and macrophages interact during vascular mineralization?

Single-cell transcriptomics demonstrates that osteoblast-like vascular smooth muscle cells and infiltrated macrophages exhibit the highest anoikis module scores in calcified arteries. Osteoblast-like cells actively secrete mineralizing matrix components and alter cell-matrix adhesion complexes. Meanwhile, inflammatory macrophages release pro-inflammatory cytokines and matrix-degrading enzymes that accelerate local tissue injury. This reciprocal crosstalk amplifies osteogenic transdifferentiation, destabilizes vascular integrity, and perpetuates calcification cascades throughout the medial arterial wall in progressive chronic kidney disease.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice or relied upon for clinical decision-making. Healthcare professionals should exercise their independent clinical judgment and refer to the latest local and national guidelines for clinical practice.

References

Chen D et al. Integrative transcriptomic and single-cell analysis identifies anoikis-related molecular signatures in vascular calcification. Ren Fail. 2026 Dec undefined. doi: 10.1080/0886022X.2026.2704989. PMID: 42634887.

Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109(6):697-711.

Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL. Calcification of human vascular cells in vitro is correlated with apoptosis: DNA fragmentation has an active role in calcification. Circ Res. 2000;87(11):1055-1062.